Skip to main content
Aviado Research · Pillar

Cardiovascular & Circulation

What the literature actually shows about supporting heart, vessels, and lipid handling — sorted by evidence tier, not by what’s loudest in marketing. Useful whether you track lipids on a dashboard or just want to age well.

14 supplements·22 articles·3 biomarkers·Last reviewed
All supplements in this pillar

Ranked by evidence tier.

Every supplement with published evidence for Cardiovascular & Circulation. Tiering reflects the strength of the primary literature, not market popularity.

Strong
Moderate
Preliminary
Insufficient
No supplements in this tier yet.
Frequently asked

Questions Aviado Research hears on this pillar.

Why does Aviado lead with Apo-B instead of LDL-C?

Editorial draft pending — Apo-B counts atherogenic particles directly; LDL-C estimates cholesterol per particle and can underestimate risk in metabolic dysfunction. Brief, citation-light, no testing-imperative.

How do evidence tiers apply to this pillar specifically?

Editorial draft pending — Restate the 4-tier rubric with cardiovascular examples. Note that hard outcome trials (MACE, mortality) are weighted more heavily than surrogate-endpoint trials when the literature offers both.

Where do supplements fit alongside statins, PCSK9s, or BP meds?

Editorial draft pending — Adjunct framing only. Aviado does not position supplements as substitutes for prescribed therapy. Cross-link to /methodology/ for how interaction risks are flagged.

How often is this pillar refreshed?

Editorial draft pending — Quarterly cadence; out-of-band re-reviews triggered by new meta-analyses, regulatory action (e.g. red-yeast-rice rulings), or safety signals.

Heart and vessels, tiered honestly.

Browse every article in this pillar filtered by evidence tier, supplement, biomarker, or sub-theme.

Explore the full library →